ArticleEMBO reports2026
BBX maintains mammalian brain development by repressing p53-mediated p21 expression.
Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Brain development requires coordinated regulation of neural stem cell (NSC) proliferation, differentiation, and neuronal migration. Here, we identify bobby sox homolog (BBX), a nuclear HMG box domain-containing protein enriched in mouse embryonic cortical germinal zones, as a regulator of corticogenesis. In the embryonic cortex, BBX depletion reduces SOX2-expressing NSCs, promotes premature cell-cycle exit, disrupts cortical cell positioning, causes abnormal clustering of newborn neurons, and impairs migratory neuron morphology. RNA-seq and public ChIP-seq analyses, together with biochemical assays, show that BBX interacts with p53 and suppresses p53-dependent p21 expression. Consistent with activation of the p21 pathway, BBX knockdown increases premature cell-cycle exit and senescence-associated features, including γH2AX accumulation and senescence-associated gene expression. Co-depletion of p21 rescues BBX knockdown-induced defects in NSC maintenance, neuronal distribution, and morphology. In line with this, depletion of retinoblastoma protein (RB), a major mediator of p21-dependent senescence, restores abnormal cortical cell distribution. These findings indicate that BBX maintains normal cortical development by restraining the p53-p21-RB axis, thereby preventing premature cell-cycle exit and senescence in developing neural cells.
Identifiers
42791352What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.